# Unraveling the metabolic pathways between atherosclerosis and sarcopenia

## TL;DR

This paper explores how aging-related conditions like atherosclerosis and sarcopenia interact and worsen each other, suggesting new ways to treat them together.

## Contribution

The paper introduces a geroscience-based approach to managing sarcopenia and atherosclerosis by targeting shared metabolic pathways.

## Key findings

- Skeletal muscle dysfunction worsens insulin resistance and inflammation, accelerating atherosclerosis.
- Atherosclerosis-induced vascular impairment leads to muscle ischemia and metabolic decline.
- Integrated interventions targeting shared pathways may improve outcomes in aging populations.

## Abstract

Sarcopenia and atherosclerosis are age-related conditions pathologically intertwined through a self-reinforcing, bidirectional cycle. This review dissects the core mechanistic pillars of this synergy such as insulin resistance, chronic low-grade inflammation, ectopic lipid deposition, and hormonal dysregulation. We detail how skeletal muscle dysfunction exacerbates systemic insulin resistance and inflammatory cascades that accelerate endothelial damage and atherogenesis. Conversely, atherosclerotic vascular impairment compromises microcirculatory function, inducing muscle ischemia and metabolic decline. Beyond pathogenesis, we evaluate integrated intervention, including combined exercise, anti-inflammatory diets, and pleiotropic pharmacotherapies, that concurrently target shared pathways in muscle and vasculature. By framing this comorbidity within the context of aging hallmarks, we advocate a paradigm shift from organ-specific management toward a holistic, geroscience-based approach to mitigate frailty and disability in the aging population.